Screener
Solventum SOLV Q2 2026 earnings
Reported August 5, 2026 · After market close
Revenue$2.2BBeat by $55.0M
EPS$2.55Beat by $0.65
Revenue estimate$2.2B
EPS estimate$1.90
“The Solventum team delivered another quarter of strong execution with results ahead of our expectations while continuing to advance our transformation. We remain on track to achieve our long-term objectives as we build a more focused, dedicated MedTech company, well-positioned to create long-term shareholder value.”
Next report
Nov 5, 2026 (in 2 months)Revenue estimate$1.9B
EPS estimate$1.35
Valuation & ratios
Segments
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Solventum report Q2 2026 earnings?
- Solventum (SOLV) reported Q2 2026 earnings on August 5, 2026 after market close.
- What were Solventum's Q2 2026 revenue and EPS?
- Solventum reported revenue of $2.2B and eps of $2.55 for Q2 2026.
- Did Solventum beat estimates in Q2 2026?
- Revenue beat the consensus estimate of $2.2B by $55.0M. EPS beat the consensus estimate of $1.90 by $0.65.
- How did Solventum's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 2.2% from $2.2B a year earlier and eps grew 50.9% from $1.69.
- Where can I find Solventum's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001964738-26-000043) and the 10-Q periodic report (0001964738-26-000047) directly on SEC EDGAR. The filing index links above go to sec.gov.
